A new mouse esophageal cancer cell line (mEC25)-derived pre-clinical syngeneic tumor model for immunotherapy

Cancer Commun (Lond). 2020 Jul;40(7):316-320. doi: 10.1002/cac2.12066. Epub 2020 Jun 8.

Authors

Tuxiong Huang¹, Jiao Yang¹, Beilei Liu², Li Fu¹

Affiliations

¹ Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Department of Pharmacology and Shenzhen University International Cancer Center, Shenzhen University Health Science Center, Shenzhen, Guangdong, 518037, P. R. China.
² Department of Clinical Oncology, the University of Hong Kong, Hong Kong, 999077, P. R. China.

No abstract available

Keywords: esophageal cancer; immunotherapy; syngeneic mouse model.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Cell Line, Tumor*
Esophageal Neoplasms*
Immunotherapy*
Mice